Rockwell Automation Joined Digital CMC Consortium
The addition signals a move toward standardized digital protocols to accelerate drug development pipelines.
Updated on Oct. 9, 2026 in Biotech
Live Poll
Do you believe the digital standardization of drug development improves the industry for patients?
Rockwell Automation has officially joined the Digital CMC Consortium as a founding member. The group aims to modernize pharmaceutical development by replacing manual, document-based workflows with standardized digital specifications.
Why it matters
The pharmaceutical sector remains heavily reliant on manual analogue methods that slow the production of increasingly complex and personalized treatments. Standardizing digital specifications is a critical step in enabling faster, more reliable biomanufacturing workflows.
The Digital CMC Consortium now comprises eight member organizations focused on pre-competitive data standards. In the past six months, the group has successfully developed two standardized digital specifications to replace traditional paper-based document workflows.
The players
Rockwell Automation
An industrial automation and digital transformation firm specializing in software and hardware architectures for manufacturing efficiency.
Digital CMC Consortium
A collaborative industry group dedicated to creating common digital standards for pharmaceutical chemistry, manufacturing, and control.
The details
The Digital CMC Consortium develops common digital specifications to align drug development processes across the industry. By moving away from manual, document-based methods—which require humans to physically transcribe or verify information between siloed systems—the consortium intends to create a machine-readable data environment. This digital infrastructure is designed to facilitate the rapid iteration required for advanced, personalized therapeutic products.
Timeline
Rockwell Automation joined the consortium in October 2026.
The consortium produced two digital specifications within the past six months.
The Tech Race
This move follows the established operational trajectory of the Digital CMC Consortium in its bid to unify industry-wide manufacturing standards. By expanding its membership, the group strengthens its position to challenge long-standing, manual-heavy practices in global pharmaceutical production.
Pharmaceutical manufacturers should expect increased pressure to adopt these new digital specifications as they become the industry standard for development workflows. This transition will ultimately reduce human error in manufacturing processes while accelerating the timeline for bringing complex therapies to market.
The takeaway
The shift toward standardized digital protocols is essential for managing the complexity of modern personalized medicine. Watch for further adoption of these specifications across the eight member organizations as a barometer for how quickly the broader pharmaceutical industry can abandon manual workflows.
Further reading
Explore more developments in the Biotech sector as industry leaders pivot toward automated manufacturing.
Source note: This article includes information reported by Mobile World Live.
Live Poll
Do you believe the digital standardization of drug development improves the industry for patients?
